Finding an effective antidepressant can be as hit-or-miss as finding a drinkable cappuccino in a strip mall…or a date-able date on Tinder. And we’re not being flip. “Part of the challenge of ...

(The Conversation) – Have you ever wondered why certain medications don’t seem to work as well for you as they do for others? This variability in drug response is what pharmacogenomic testing hopes to ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

Pharmacogenomics, the study of how genetic variations influence medication response, is one of the most widely used forms of precision medicine. Understanding a patient’s unique genetic makeup helps ...

STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics ...

Expert Rev Mol Diagn. 2012;12(8):841-855. From their experience with PGx testing, the authors believe that this clinical utility in primary care is possible. For instance, the authors recently ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - Capecitabine and 5-FU are used for the treatment of colorectal, esophageal, stomach, ...

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc.

STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA ...